HOME >> MEDICINE >> NEWS
Detrol LA combined with standard treatment for enlarged prostate is twice as effective

New York, November 4, 2004 Combination therapy with Pfizer Inc's DETROL LA (tolterodine tartrate extended release capsules) and an alpha blocker, a standard treatment for enlarged prostate, was twice as effective in relieving overactive bladder (OAB) symptoms as the alpha blocker alone in men with both bladder obstruction and OAB, according to a study published in the October issue of the British Journal of Urology. Six million American men suffer from a combination of a common complication of enlarged prostate called bladder outlet obstruction, which reduces or prevents urine flow, and OAB, a medical condition associated with involuntary contractions of the bladder muscle.

"There is overlap in the symptoms of bladder outlet obstruction and overactive bladder, so current clinical practice entails treating bladder obstruction first, and adding a therapy like DETROL LA only if the man continues to suffer for several months from urgency, frequency and excessive urination at night," said study author Dr. Michael Chancellor, professor of urology at the University of Pittsburgh. "These findings suggest that combination therapy is well tolerated and can be considered for men with or without bladder obstruction."

The prospective study divided 144 men into two groups, those with bladder obstruction only (n=76) and those with bladder obstruction plus OAB (n=68). All patients were treated with alpha blocker doxazosin for three months. In patients with no symptomatic improvement, DETROL LA was added for an additional three months. Seventy-three percent of men with bladder obstruction and OAB reported an improvement during the combination therapy phase of the study compared to 35 percent reporting improvement in the initial doxazosin alone phase.

The most common side effects of doxazosin were dizziness, postural hypotension and abnormal ejaculation. The most common side effect of DETROL LA was dry mouth. There was a low incidence (3.3 percen
'"/>


4-Nov-2004


Page: 1 2 3

Related medicine news :

1. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
2. Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights
3. Nicotine more addictive when combined with other tobacco smoke chemicals, UCI study finds
4. Cognitive behavioral therapy combined with antidepressant effective in treating adolescent OCD
5. Heart disease kills more women annually than all cancers combined
6. Stents combined with clot-busting drugs effective in limiting impact of deadly form of stroke
7. Study shows people with Alzheimers can benefit from exercise combined with caregiver training
8. Wyeth chemists honored for Prevnar first combined pneumococcal vaccine for infants
9. Task force issues caution on combined hormone therapy
10. University of Pittsburgh research shows combined PET/CT finds cancerous lesions standard CT misses
11. Some patients are candidates for combined heart bypass, lung transplant surgeries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/2/2018)... ... September 01, 2018 , ... ... proud to add HydraFacial MD® Elite to its leading menu of results-driven ... vortex-suction technology and an infusion of clinically-proven ingredients to dramatically improve your ...
(Date:9/1/2018)... ... August 31, 2018 , ... Alice Branton shared her ... research health issues with Daytime host Jerry Penacoli. , With all the medical ... Vitamin D deficiency is a major public health problem worldwide irrespective of age, location, ...
(Date:8/31/2018)... ... 2018 , ... Kessler Foundation, a major center for rehabilitation ... In the MRI Simulator, the individual experiences the conditions of an actual magnetic ... research participants become accustomed to the sights and sounds of the actual scan, ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... the impact of a biofield energy treated nutraceutical to improve overall immunity and ... immune function and blood, as well as, inflammation. The following data was reported:, ...
(Date:8/31/2018)... (PRWEB) , ... August 31, ... ... on VERALOX Therapeutics Inc.’s “hit” list. The company, a small molecule drug ... (FITCI), launched in September 2017 with a mission to develop a first-in-class ...
Breaking Medicine News(10 mins):
(Date:9/1/2018)... Ga. (PRWEB) , ... September 01, 2018 , ... ... Group, Inc. ( Shaw ) focuses on the company’s continued efforts to “Create ... contribute to healthier environments and preservation of natural resources. , “2017 was ...
(Date:8/31/2018)... ... August 31, 2018 , ... ... acquire, such as medications for cancer, mental health and required blood clotting agents ... treat Respiratory Distress Syndroms (RDS) in premature babies and can be cost prohibitive ...
(Date:8/31/2018)... ... August 31, 2018 , ... The summertime sweat that ... who suffer from a condition known as hyperhidrosis. In Grand Rapids , Dr. ... as men and women alike frequently soak through their shirts for no reason other ...
Breaking Medicine Technology:
Cached News: